Medicine in China

Q&A: Transcenta sees promising future in biologics

The biopharmaceutical startup backed by Lilly Asia Ventures, Temasek and Sequoia China is looking both at its next round of funding and at an IPO next year.

Over the past five years, biotech investment has experienced the fastest development in China. Pharmaceutical companies have become a rising force that has attracted increasing amount of capital.  

¬ Haymarket Media Limited. All rights reserved.

Sign In to Your Account Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media